KEROS THERAPEUTICS INC (KROS) Stock Earnings Estimates
NASDAQ:KROS • US4923271013
15.52 USD
-0.19 (-1.21%)
At close: Feb 24, 2026
15.55 USD
+0.03 (+0.19%)
After Hours: 2/24/2026, 8:00:02 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 151K | 3.55M 2,250.99% | 248.46M 6,898.87% | 9.812M -96.05% | 3.006M -69.36% | 62.921M 1,993.18% | 81.185M 29.03% | 115.6M 42.39% | 211.92M 83.32% | 320.33M 51.16% | 312.99M -2.29% | |
| EBITDA YoY % growth | -114.12M -103.82% | -169.126M -48.20% | -209.604M -23.93% | 72.716M 134.69% | -80.988M -211.38% | -83.232M -2.77% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -114.79M -103.64% | -169.941M -48.05% | -210.833M -24.06% | 52.416M 124.86% | -159.397M -404.10% | -168.722M -5.85% | -169.58M -0.51% | -197.118M -16.24% | -218.032M -10.61% | -239.767M -9.97% | -221.612M 7.57% | 87.832M 139.63% | |
| Operating Margin | N/A | -112,543.71% | -5,938.96% | 21.10% | -1,624.51% | -5,612.85% | -269.51% | -242.80% | -188.61% | -113.14% | -69.18% | 28.06% | |
| EPS YoY % growth | -4.15 -64.68% | -5.20 -25.30% | -5.01 3.65% | 2.19 143.70% | -3.30 -250.91% | -3.62 -9.64% | -2.66 26.55% | -2.77 -3.99% | -2.45 11.52% | -0.70 71.25% | 0.60 185.03% | 1.56 160.22% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.64 43.74% | -0.74 -120.51% | -0.77 -1.46% | -0.38 -110.80% | -0.94 -47.12% | -0.77 -3.02% | -0.77 0.79% | -0.66 -74.73% | -0.58 38.38% |
| Revenue Q2Q % growth | 2.812M -7.56% | 502.86K -99.76% | 507.96K -97.20% | 641.325K -95.50% | 647.7K -76.97% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -28.774M 44.69% | -29.274M -119.21% | -30.631M 21.67% | 29.009M 303.22% | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -35.321M 33.67% | -37.324M -124.55% | -38.478M 3.36% | -26.071M -69.47% | -36.588M -3.59% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.18 87.23% | -1.07 | 0.89 | 83.15% |
| Q2 2025 Q2Q % growth | -0.76 39.20% | -1.15 | 0.39 | 34.17% |
| Q1 2025 Q2Q % growth | 3.62 399.17% | -0.25 | 3.87 | 1,560.50% |
| Q4 2024 Q2Q % growth | -1.14 14.93% | -1.00 | -0.14 | -13.69% |
| Q3 2024 Q2Q % growth | -1.41 -6.02% | -1.30 | -0.11 | -8.05% |
| Q2 2024 Q2Q % growth | -1.25 1.57% | -1.26 | 0.01 | 0.53% |
| Q1 2024 Q2Q % growth | -1.21 3.97% | -1.37 | 0.16 | 11.93% |
| Q4 2023 Q2Q % growth | -1.34 -22.94% | -1.40 | 0.06 | 4.43% |
| Q3 2023 Q2Q % growth | -1.33 -44.57% | -1.37 | 0.04 | 3.25% |
| Q2 2023 Q2Q % growth | -1.27 -12.39% | -1.37 | 0.10 | 6.98% |
| Q1 2023 Q2Q % growth | -1.26 -24.75% | -1.15 | -0.11 | -10.01% |
| Q4 2022 Q2Q % growth | -1.09 -263.33% | -1.12 | 0.03 | 2.60% |
| Q3 2022 Q2Q % growth | -0.92 -5.75% | -1.26 | 0.34 | 26.77% |
| Q2 2022 Q2Q % growth | -1.13 -68.66% | -1.08 | -0.05 | -4.71% |
| Q1 2022 Q2Q % growth | -1.01 -48.53% | -0.88 | -0.13 | -14.81% |
| Q4 2021 Q2Q % growth | -0.30 38.78% | -0.94 | 0.64 | 67.94% |
| Q3 2021 Q2Q % growth | -0.87 -45.00% | -0.74 | -0.13 | -18.05% |
| Q2 2021 Q2Q % growth | -0.67 -8.06% | -0.67 | 0.00 | -0.28% |
| Q1 2021 Q2Q % growth | -0.68 86.69% | -0.59 | -0.09 | -14.94% |
| Q4 2020 Q2Q % growth | -0.49 | -0.58 | 0.09 | 15.72% |
| Q3 2020 Q2Q % growth | -0.60 | -0.61 | 0.01 | 1.14% |
| Q2 2020 Q2Q % growth | -0.62 | -0.69 | 0.07 | 9.95% |
| Q1 2020 Q2Q % growth | -5.11 | -0.38 | -4.73 | -1,254.00% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 14.262M 3,575.77% | 3.876M | 10.386M | 267.96% |
| Q2 2025 Q2Q % growth | 18.168M 49,002.70% | 2.822M | 15.346M | 543.80% |
| Q1 2025 Q2Q % growth | 211.246M 254,413.25% | 2.227M | 209.019M | 9,385.68% |
| Q4 2024 Q2Q % growth | 3.042M 2,027.27% | 15.732M | -12.69M | -80.66% |
| Q2 2023 Q2Q % growth | 165.75K | -165.75K | -100.00% | |
| Q1 2023 Q2Q % growth | 221.003K | -221.003K | -100.00% | |
| Q4 2022 Q2Q % growth | -100.00% | 874.283K | -874.283K | -100.00% |
| Q2 2022 Q2Q % growth | -100.00% | % | ||
| Q1 2022 Q2Q % growth | 6.12M | -6.12M | -100.00% | |
| Q3 2020 Q2Q % growth | 63.75K | -63.75K | -100.00% | |
| Q2 2020 Q2Q % growth | 63.75K | -63.75K | -100.00% | |
| Q1 2020 Q2Q % growth | 84.997K | -84.997K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -6.77% | 8.38% | 0% | 140.55% |
| Revenue | 0% | 0% | -0.37% | 3.57% |